AI in Biotech: What Actually Works, and What's Quietly Failing
AI is reshaping drug discovery, diagnostics, and therapeutic development. But there's a wide gap between what AI is hyped to do and what actually holds up at the bench. This panel brings together founders, operators, and investors building Seattle biotech for an honest conversation about that gap: where AI genuinely accelerates the science today, where it's failing quietly, and why deep domain expertise, not the tool on its own, is what separates the two.
Panelists:
Adam Moyer, Co-founder and VP of Molecular Design, Vilya
Daniel Wright, VP of Operations, Vilya
Ti Zhao, Partner, Pack Ventures
Alex Federation, Co-founder and CEO, Talus Bio
Who it's for:
Biotech and life sciences founders, operators, and investors, plus anyone building or funding AI-driven drug discovery, diagnostics, or therapeutics in the Seattle ecosystem.
Format:
5:00 pm — Arrival
5:15 pm to 5:55 pm— Panel
5:55 pm to 6:05 pm — Q&A
6:05 pm to 7:00 pm — Networking
Light refreshments and drinks provided.
Hosted by Shamila Nadir, PhD medicinal chemist, UW Foster affiliate faculty, and founder of LemiLeap Bio, a biotech competitive-intelligence company.
Venue proudly sponsored by the University of Washington Foster School of Business, MS in Entrepreneurship program
Visitor Parking
Use the online Pay by Phone parking app to park in self-pay lots N01 or N20/N21.
Note: N01 (in front of the Burke Museum) is frequently full. The Central Plaza Garage and N20/21 lots are your next best options — plan a few extra minutes to walk from there.
· Map of self-pay parking lots
· Map of Seattle campus : the event is near the north gatehouse.
ADA Accommodations
If you need disability accommodations, the Gatehouse Parking Specialist can direct you to the nearest ADA stall. ADA guests can use permits in any open ADA space in any lot with the correct credentials.
Questions or need help with parking arrangements? Contact UW Transportation Services, Events Office at (206) 616-8710.